07:00 , Mar 23, 2015 |  BioCentury  |  Emerging Company Profile

Complementary edge

The neurological manifestations of many lysosomal storage disorders are poorly treated because it hasn't been possible to get enough of an enzyme or gene therapy vector across the blood-brain barrier to replace dysfunctional proteins. Abeona...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Financial News

Abeona completes venture financing

Abeona Therapeutics LLC Cleveland, Ohio   Business: Endocrine/Metabolic   Date completed: 2014-12-01   Type: Venture financing   Raised: $3.6 million   Investors: Cure Sanfilippo Foundation; Sanfilippo Research Foundation; Team Sanfilippo; Abby Grace Foundation; National MPS...